期刊文献+

血清cTnI对病毒性心肌炎诊断价值的研究 被引量:7

Diagnostic values of serum cardiac troponin I in the patients with viral myocarditis
暂未订购
导出
摘要 目的 分别观察多种病毒感染后血清心肌肌钙蛋白I(cTnI)变化 ,结合心电图 (ECG)及临床特征 ,阐述其对病毒性心肌炎 (VMC)心肌损伤的诊断价值。方法与结果 VMC患者 180例ELISA双抗夹心法定量测定血清cTnI ,升高 97例 (5 4% ) ,其中重症 19例、有病毒感染史与ECG改变 2 7例血清cTnI均增高。 19例丙型病毒性肝炎患者 ,8例血清cTnI增高。 5 0例带状疱疹病毒感染者 2 0例血清cTnI增高 ,且与临床严重度有关 ,其中 17例ECG呈多样性表现。 6 5例VMC且cTnI持续增高者在病程 1、3、6、9、12个月时转阴率分别为 47 7%、5 2 3%、90 8%、92 3 %、98 5 %。 Objective To evaluated the diagnostic values of serum cardiac troponin I(cTnI)in the patients with viral myocarditis(VMC) according to the data from individual analysis of the electrocardiograms(ECG)and clinical symptoms,serum cTnI levels.Method and Result Seurm cTnI level was assayed by ELISA method with two monoclonal antibodies against cTnI.Seurm cTnI level was elevated in 97 of 180 patients that was 54% myocarditis following the diagnostic criteria issued 1995.The rate of serum cTnI increased in all 19 serious patients (Ⅱ or Ⅲ A V Block,heart failure)was 100%.Serum cTnI levels were elevated in 20 of 50 patients with varicella zoster myocarditis,and in which only 17 of 20 patients had abnormal unspecific change of ECG.The rate of cTnI turned to be negative at 1,3,6,9 and 12 months in 65 cases of VMC were 47 7%,52 3%,90 8%,92 3% and 98 5% respectively.Conclusion Serum cTnI is a highly sensitive and specific marker for determining cardiac injury and detecting myocyte injury in patients infected with several viruses.
出处 《江苏医药》 CAS CSCD 2000年第10期753-754,共2页 Jiangsu Medical Journal
基金 国家"九五"攻关基金!(96 90 60213) 江苏省科委社会发展基金!(BS9702 8与BS980 39) 江苏省卫生厅项目!(H970 1)
关键词 心肌肌钙蛋白Ⅰ 病毒性心肌炎 诊断价值 研究 Cardiac troponin Ⅰ Viral myocarditis
  • 相关文献

参考文献3

二级参考文献5

  • 1张寄南,中华心血管病杂志,1997年,25卷,379页
  • 2Fu L X,Clin Immunol Immunopathol,1996年,78卷,203页
  • 3Fu L X,Int J Cardiol,1996年,54卷,127页
  • 4杨英珍,临床心血管病杂志,1995年,11期,376页
  • 5李延文,上海医科大学学报,1993年,20卷,472页

共引文献162

同被引文献77

  • 1程志清.陆芷青诊治病毒性心肌炎经验述要[J].浙江中医杂志,1993,28(5):196-197. 被引量:4
  • 2惠宏襄,赵小宁,金明,王成济,莫简.自由基与细胞凋亡[J].生物化学与生物物理进展,1996,23(1):12-16. 被引量:68
  • 3[1]Causes of death. United States Renal Data System. Am J Kidney Dis,19 98,32:S81-88
  • 4[2]Karin Tyralla, Kerstin Amann. Cardiovascular changes in renal failure .Blood Purif, 2002,20(5):462-465
  • 5[5]Per venge M, Bo Lagerqvist M, Erik Diderholm M ,et al.Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol, 2002,89:1035-1041
  • 6[6]Orrow DA, Rifai N, Tanasijevic MJ,et al. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes:a Thrombolysis In Myocardial Infarction (TIMI)11B Substudy.Clin Chem,2000,46(4):453-60
  • 7[7]Mclaurin MD, Apple FS, Voss EM,et al.Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem, 199 7,43:976-982
  • 8[8]Lang S, Schindler C, Forberger G, et al. Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end-stage renal failure. Clinnical Nephrology, 2001,56(1):44-51
  • 9[9]Daylily S.Deborah Z,Janet G,et al.Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clinical Chemistry,2001,47(3):412-417
  • 10[10]Luis Gruberg, Shmuel Fuchs, Ron Waksman, et al.Prognostic value of cardiac troponin I elevayion after percutaneous coronary intervention in patients with chronic renal insufficiency:a 12-month outcome analysis.Catheterization and Cardiovascular interventions, 2002,55:174-179

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部